LNC THERAPEUTICS
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy of STABLOR® on Visceral Fat Mass Reduction in Patients With Metabolic Syndrome (NCT03692806) | LNC THERAPEUTICS | 2018-09-11 |
Track LNC THERAPEUTICS automatically
Every clearance here is in the API, with alerts when new ones post.